Member Info for Cloudy390

Say Accustem will equal Tiziana SP on demerger and we shall be happy.

It’s about time we’re all in for a bonus!

Already have a connection to Tils, wouldn’t be nice if they could redeem their bad judgement with Inhibitex with Tils.

I thought as well markygee

https://www.thetakeoverpanel.org.uk/the-code/download-code
Interesting read!

His buy was just a little reminder that buys are in order.

Make a bid for the company!
When a person or group acquires interests in shares carrying 30% or more of the voting rights of a company, they must make a cash offer to all other shareholders at the highest price paid in the 12 months before the offer was announced (30% of the voting rights of a company is treated by the Code as the level at which effective control is obtained

300,000 traded shares dictates the price of 200,000,000 shares, what a lot of b.ll.cks!
Lunacy..

Trying to figure out what’s going on is very hard and may drive you around the bend.!

Here’s a thought.
Tils sold for fair price, GC pumps monies into Stem and Okyo and dilutes the ........ out of us alll.

Will get rid of Stem shares.

Has got his head in them again.
I reckon Tils 501 expediated trial is on the cards for COVID, and Ards.
MS trial extended access will begin with other patients added as suitability of treatment goes forward. Crohns will go ahead as well.
Tils 401 for COVID is going ahead, as stated previously,maybe combined with 501 as things progress.
Milciclib will find a partner to progress in Japan etc.
Tils will have a massive fund raise with GC getting another bonus when all results are confirmed phenomenal, at £5 +. Or bought out.

All what was planned for Tils 501 has been completed ie GMC manufacture of drug, trial in monkeys,nebuliser manufacture. All we need now is trial date!!!

What a tractor looks like. LOL.
Seriously tho something should be ringing in ya head, why the delay...........! Somethings going on, we are gonna be fleeced or rewarded, you choose!

All will be sorted soon, up up and away!

Not being in when news drops, simples.

It must be a new interview surely, perhaps it will replace the old interveiw on YouTube when it’s been aired tonight?

And you live up to your name!

Accustem will launch at the same time on LSE and Nasdaq at the same time!

Good find moosof, pretty sure it’s no us ,but confirms Tils getting the patent for use in car t therapy.
Interesting bit in news you linked to
A month later I went back to have the CAR T-cells put in. This took only a few minutes and was painless. But after a week I became ill with something called cytokine release syndrome — basically a massive overreaction by my immune system.

Our mabs reduce cytokine storms which could help greatly in Car-T therapy.